Corrigendum to: Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition (EMBO reports, (2017), 18, 1, (150-168), 10.15252/embr.201642360)

Young Dong Yoo, Dae Hee Lee, Hyunjoo Cha-Molstad, Hyungsin Kim, Su Ran Mun, Changhoon Ji, Seong Hye Park, Ki Sa Sung, Seung A. Choi, Joonsung Hwang, Deric M. Park, Seung Ki Kim, Kyung Jae Park, Shin Hyuk Kang, Sang Cheul Oh, Aaron Ciechanover, Yong J. Lee, Bo Yeon Kim, Yong Tae Kwon

Research output: Contribution to journalComment/debate

2 Citations (Scopus)

Abstract

The affiliations of Joonsung Hwang, Deric Park and Bo Yeon Kim were listed incorrectly. The authors have confirmed that JH and BYK are affiliated with World Class Institute, Anticancer Agents Research Center, Korea Research Institute of Bioscience & Biotechnology, Ochang Cheongwon, Korea. These authors have never been affiliated with Korea University Department of Neurosurgery. DP is affiliated with Neuro-Oncology Branch, CCR, NCI, National Institutes of Health in addition to the University of Virginia. The authors apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)1671
Number of pages1
JournalEMBO Reports
Volume18
Issue number9
DOIs
Publication statusPublished - 2017 Sep 1

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Yoo, Y. D., Lee, D. H., Cha-Molstad, H., Kim, H., Mun, S. R., Ji, C., Park, S. H., Sung, K. S., Choi, S. A., Hwang, J., Park, D. M., Kim, S. K., Park, K. J., Kang, S. H., Oh, S. C., Ciechanover, A., Lee, Y. J., Kim, B. Y., & Kwon, Y. T. (2017). Corrigendum to: Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition (EMBO reports, (2017), 18, 1, (150-168), 10.15252/embr.201642360). EMBO Reports, 18(9), 1671. https://doi.org/10.15252/embr.201744761